Pharmacokinetics and pharmacodynamics modeling of lonafarnib in patients with chronic hepatitis delta virus infection.
Saved in:
| Title: | Pharmacokinetics and pharmacodynamics modeling of lonafarnib in patients with chronic hepatitis delta virus infection. |
|---|---|
| Authors: | Canini L; Program for Experimental and Theoretical Modeling Division of Hepatology, Loyola University Medical Center Maywood IL.; Centre for Immunity Infection and Evolution, University of Edinburgh Edinburgh United Kingdom., Koh C; Translational Hepatology Unit Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health Bethesda MD., Cotler SJ; Program for Experimental and Theoretical Modeling Division of Hepatology, Loyola University Medical Center Maywood IL., Uprichard SL; Program for Experimental and Theoretical Modeling Division of Hepatology, Loyola University Medical Center Maywood IL., Winters MA; Department of Medicine Division of Gastroenterology and Hepatology and Department of Microbiology and Immunology, Stanford School of Medicine Stanford CA., Han MAT; Translational Hepatology Unit Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health Bethesda MD., Kleiner DE; Laboratory of Pathology National Cancer Institute, National Institutes of Health Bethesda MD., Idilman R; Department of Gastroenterology Ankara University Ankara Turkey., Yurdaydin C; Department of Gastroenterology Ankara University Ankara Turkey., Glenn JS; Department of Medicine Division of Gastroenterology and Hepatology and Department of Microbiology and Immunology, Stanford School of Medicine Stanford CA., Heller T; Translational Hepatology Unit Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health Bethesda MD., Dahari H; Program for Experimental and Theoretical Modeling Division of Hepatology, Loyola University Medical Center Maywood IL. |
| Source: | Hepatology communications [Hepatol Commun] 2017 May 19; Vol. 1 (4), pp. 288-292. Date of Electronic Publication: 2017 May 19 (Print Publication: 2017). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 101695860 Publication Model: eCollection Cited Medium: Internet ISSN: 2471-254X (Electronic) Linking ISSN: 2471254X NLM ISO Abbreviation: Hepatol Commun Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 29404459 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Pharmacokinetics and pharmacodynamics modeling of lonafarnib in patients with chronic hepatitis delta virus infection. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Canini+L%22">Canini L</searchLink>; Program for Experimental and Theoretical Modeling Division of Hepatology, Loyola University Medical Center Maywood IL.; Centre for Immunity Infection and Evolution, University of Edinburgh Edinburgh United Kingdom.<br /><searchLink fieldCode="AU" term="%22Koh+C%22">Koh C</searchLink>; Translational Hepatology Unit Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health Bethesda MD.<br /><searchLink fieldCode="AU" term="%22Cotler+SJ%22">Cotler SJ</searchLink>; Program for Experimental and Theoretical Modeling Division of Hepatology, Loyola University Medical Center Maywood IL.<br /><searchLink fieldCode="AU" term="%22Uprichard+SL%22">Uprichard SL</searchLink>; Program for Experimental and Theoretical Modeling Division of Hepatology, Loyola University Medical Center Maywood IL.<br /><searchLink fieldCode="AU" term="%22Winters+MA%22">Winters MA</searchLink>; Department of Medicine Division of Gastroenterology and Hepatology and Department of Microbiology and Immunology, Stanford School of Medicine Stanford CA.<br /><searchLink fieldCode="AU" term="%22Han+MAT%22">Han MAT</searchLink>; Translational Hepatology Unit Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health Bethesda MD.<br /><searchLink fieldCode="AU" term="%22Kleiner+DE%22">Kleiner DE</searchLink>; Laboratory of Pathology National Cancer Institute, National Institutes of Health Bethesda MD.<br /><searchLink fieldCode="AU" term="%22Idilman+R%22">Idilman R</searchLink>; Department of Gastroenterology Ankara University Ankara Turkey.<br /><searchLink fieldCode="AU" term="%22Yurdaydin+C%22">Yurdaydin C</searchLink>; Department of Gastroenterology Ankara University Ankara Turkey.<br /><searchLink fieldCode="AU" term="%22Glenn+JS%22">Glenn JS</searchLink>; Department of Medicine Division of Gastroenterology and Hepatology and Department of Microbiology and Immunology, Stanford School of Medicine Stanford CA.<br /><searchLink fieldCode="AU" term="%22Heller+T%22">Heller T</searchLink>; Translational Hepatology Unit Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health Bethesda MD.<br /><searchLink fieldCode="AU" term="%22Dahari+H%22">Dahari H</searchLink>; Program for Experimental and Theoretical Modeling Division of Hepatology, Loyola University Medical Center Maywood IL. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101695860%22">Hepatology communications</searchLink> [Hepatol Commun] 2017 May 19; Vol. 1 (4), pp. 288-292. <i>Date of Electronic Publication: </i>2017 May 19 (<i>Print Publication: </i>2017). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wolters+Kluwer+Health%2C+Inc%22">Wolters Kluwer Health, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101695860 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2471-254X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222471254X%22">2471254X </searchLink><i>NLM ISO Abbreviation: </i>Hepatol Commun <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29404459 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/hep4.1043 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 288 Titles: – TitleFull: Pharmacokinetics and pharmacodynamics modeling of lonafarnib in patients with chronic hepatitis delta virus infection. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Canini L – PersonEntity: Name: NameFull: Koh C – PersonEntity: Name: NameFull: Cotler SJ – PersonEntity: Name: NameFull: Uprichard SL – PersonEntity: Name: NameFull: Winters MA – PersonEntity: Name: NameFull: Han MAT – PersonEntity: Name: NameFull: Kleiner DE – PersonEntity: Name: NameFull: Idilman R – PersonEntity: Name: NameFull: Yurdaydin C – PersonEntity: Name: NameFull: Glenn JS – PersonEntity: Name: NameFull: Heller T – PersonEntity: Name: NameFull: Dahari H IsPartOfRelationships: – BibEntity: Dates: – D: 19 M: 05 Text: 2017 May 19 Type: published Y: 2017 Identifiers: – Type: issn-electronic Value: 2471-254X Numbering: – Type: volume Value: 1 – Type: issue Value: 4 Titles: – TitleFull: Hepatology communications Type: main |
| ResultId | 1 |